David W. Dodick, MD
Advertisement
Director, Concussion and Headache Programs, Mayo Clinic; Chair, American Brain Foundation, IHS-Global Patient Advocacy Coalition
Articles by David W. Dodick, MD
Here: highlights from a systematic review that these authors view as a substantial step forward in establishing an evidence-based approach to migraine treatment in the acute care setting.
Advertisement
Latest Updated Articles
Therapies in Development for Acute MigraineOctober 30th 2020
Gepants for Acute Migraine: Safety & Efficacy DataOctober 30th 2020
Treating Acute Migraine in the Community SettingOctober 30th 2020
Advances in the Treatment of Acute MigraineOctober 30th 2020
Real-World Experience With Gepants for Acute MigraineOctober 30th 2020
Ubrogepant: Treatment for Acute MigraineOctober 30th 2020
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Tau PET Tracer MK-6240 for Alzheimer Diagnostic Workup
2
FDA Clears Phase 2 Trial for Demyelinating Agent Lucid-MS in Progressive Multiple Sclerosis
3
CN045 Promotes Oligodendrocyte Maturation, Modest Remyelination in Preclinical MS Study
4
Ractigen Completes Phase 2 Enrollment for RAG-17 in SOD1-ALS
5